Newport Beach-based ImmunogenX LLC, an early-stage drug developer, earlier this month said it began patient enrollment for its Phase 2b clinical trial for its treatment of celiac disease, an incurable digestive ailment that destroys the lining of the intestines...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to OCBJ.com archives
  • Book of Lists — the most comprehensive business resource in Orange County
  • NEW: Orange County 500 — influential business leaders you need to know
Yours for only $99